Tag Archives: vrx

Zoetis Backslides After Spiking On Valeant Approach

Shares of Zoetis (ZTS) are backsliding Friday following a 11.4% surge the day before on talk that Valeant was eyeing the animal-health company. Zoetis shares plummeted 9.7% to 50.01 in the stock market today. Activist investor Bill Ackman’s hedge fund, Pershing Square, is the company’s largest shareholder, with an 8.5% stake. Valeant Pharmaceuticals (VRX) reportedly made a preliminary approach to acquire the animal-health company, said the Wall

Are 4 Top-Rated IBD 50 Drug Stocks On Your Radar?

The IBD 50 is a ranking of leading stocks based on key fundamental and technical measures including earnings and sales growth, profit margins, return on equity and relative price performance. Here’s a closer look at four drug stocks that made the new list Friday: Regeneron Pharmaceuticals (REGN), Valeant Pharmaceuticals (VRX), Actavis (ACT) and Gilead Sciences (GILD). Regeneron has a highest possible IBD Composite Rating of 99. On Friday, the FDA

Meet 8 Hot Med Stocks Among IBD’s Big Cap Leaders

IBD’s Big Cap Leaders screen filters through highly liquid, large-cap stocks with a strong record of earnings growth. Eight top-notch medical stocks that made the screen’s cut are Valeant Pharmaceuticals (VRX), Gilead Sciences (GILD), Celgene (CELG), Actavis (ACT), Biogen (BIIB), Regeneron (REGN), Shire (SHPG) and Illumina (ILMN). Valeant Pharmaceuticals has a highest-possible IBD Composite Rating of 99, meaning its shares outperform 99% of all